{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:03:07Z","timestamp":1792508587230,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.radonc.2011.05.013","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T22:47:13Z","timestamp":1308610033000},"page":"86-92","source":"Crossref","is-referenced-by-count":349,"title":["Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial"],"prefix":"10.1016","volume":"100","clinical-trial-number":[{"clinical-trial-number":"isrctn71826974","registry":"10.18810\/isrctn"}],"author":[{"given":"Lisa","family":"Lowry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Benstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Illidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Linch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2011.05.013_b0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/108.3.675","article-title":"Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas","volume":"108","author":"Fuks","year":"1973","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2011.05.013_b0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/bjc.1994.213","article-title":"Clinical stage 1 non-Hodgkin\u2019s lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy","volume":"69","author":"Vaughan Hudson","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2011.05.013_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900120102","article-title":"Potential role for low dose limited field radiation therapy in advanced low grade non-Hodgkin\u2019s lymphoma","volume":"12","author":"Ganem","year":"1994","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.radonc.2011.05.013_b0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-8140(96)01854-3","article-title":"Low dose palliative radiotherapy in low grade non-Hodgkin\u2019s lymphoma","volume":"42","author":"Sawyer","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.013_b0025","doi-asserted-by":"crossref","unstructured":"Luthy SK, Ng AK, Silver B, et al.: Response to low-dose involved-field radiotherapy in patients with non-Hodgkin\u2019s lymphoma. Ann Oncol advance access published online July 22, 2008.","DOI":"10.1093\/annonc\/mdn529"},{"key":"10.1016\/j.radonc.2011.05.013_b0030","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Onc"},{"key":"10.1016\/j.radonc.2011.05.013_b0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CLM.2008.n.032","article-title":"Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study","volume":"8","author":"Murthy","year":"2008","journal-title":"Clin Lymphoma & Myeloma"},{"key":"10.1016\/j.radonc.2011.05.013_b0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0360-3016(86)90057-X","article-title":"Prognostic factors in non-Hodgkin\u2019s lymphoma","volume":"12","author":"Tubiana","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2011.05.013_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1016\/j.radonc.2011.05.013_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000012104","article-title":"Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas","volume":"58","author":"Ferreri","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2011.05.013_b0055","doi-asserted-by":"crossref","first-page":"B84","DOI":"10.1007\/PL00022798","article-title":"Consolidation radiotherapy to bulky disease in aggressive NHL First results of the NHL B-94 trial of the DSHNHL","volume":"80","author":"Rube","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.radonc.2011.05.013_b0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clon.2009.11.003","article-title":"Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients","volume":"22","author":"Jacob","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2011.05.013_b0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-8140(85)80086-4","article-title":"Role of radiation therapy in localised non-Hodgkin\u2019s lymphoma","volume":"4","author":"Sutcliffe","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.013_b0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1148\/98.2.411","article-title":"Time-dose relationships in radiation therapy of lymphosarcoma and giant follicle lymphoma","volume":"98","author":"Seydel","year":"1971","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2011.05.013_b0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/112.1.179","article-title":"Irradiation in the local control of malignant lymphoreticular tumours","volume":"112","author":"Cox","year":"1974","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2011.05.013_b0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0009-9260(84)80085-9","article-title":"Localised grade 2 non-Hodgkin\u2019s lymphoma: results of treatment with radiotherapy (BNLI report No. 24)","volume":"35","author":"Lamb","year":"1984","journal-title":"Clin Radiol"},{"key":"10.1016\/j.radonc.2011.05.013_b0085","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","article-title":"Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma","volume":"107","author":"Mosser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2011.05.013_b0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2011.05.013_b0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2011.05.013_b0100","first-page":"3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin\u2019s disease: data from the Childhood Cancer Survivor Study","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.radonc.2011.05.013_b0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clon.2007.03.011","article-title":"Radiotherapy Dose Fractionation, Access and Waiting Times in the Countries of the UK in 2005","volume":"19","author":"Williams","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2011.05.013_b0110","unstructured":"Ionising Radiation (Medical Exposure) Regulations 2000. <http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_4007957> [accessed 20 Aug 2008]."},{"key":"10.1016\/j.radonc.2011.05.013_b0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(74)91786-3","article-title":"Classification of non-Hodgkin\u2019s lymphomas","volume":"304","author":"Bennett","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2011.05.013_b0120","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, 4th edition. World Health organisation, 2008."},{"key":"10.1016\/j.radonc.2011.05.013_b0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.013_b0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Ganem","year":"2006","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814011002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814011002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T11:02:02Z","timestamp":1686135722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814011002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0167814011002052"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2011.05.013","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}